Xenter

What Xenter does

Xenter, Inc. is a privately held medical device and digital health company headquartered in Draper, Utah, founded in 2020. The company is building an integrated platform that embeds wireless capabilities into workhorse medical devices used in interventional procedures, targeting structural heart disease, coronary interventions, stroke, vascular disease, and cognitive disorders. Its architecture has four layers: (1) smart wireless medical devices (Avara Smart Device, Guru Control Handle, and Smart Device) that capture sensor, imaging, and blood-test data from the clinical environment; (2) the XenFi wireless network that transmits that data; (3) the XMD global healthcare cloud for storage and AI analytics; and (4) XenME patient and provider software applications that deliver AI-enabled clinical insights. Xenter brands its real-time, in-procedure data as "Physical Intelligence," positioning it as the substrate that makes its AI clinically meaningful, with stated capabilities in predictive analytics and automated EHR archiving.

The company's intended business model combines hardware sales (the smart devices) with subscription-based recurring revenue from the XMD cloud platform and XenME software applications, sold via an enterprise field sales motion to hospitals, health systems, and interventional medicine specialists (cardiologists, cardiac surgeons, interventional radiologists, neurologists, and vascular surgeons). All products are currently labeled "investigational devices only. Not for sale in the United States or any other jurisdiction," meaning the company is in a pre-commercial regulatory phase rather than a revenue-generating one. Xenter has raised approximately $13 million in disclosed funding (a $12 million Series A in May 2021 and a $1 million round in July 2021), maintains 51–100 employees, and has assembled a leadership team including a Founder/CEO, CTO, EVP/General Counsel, VP Regulatory Affairs & Quality Systems, VP Business Development, and Senior VP of Commercial — a configuration consistent with a company building toward FDA clearance and commercial launch.

Name

Xenter

Legal name

Xenter, Inc.

Website

https://xentermd.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Xenter develops wireless medical devices (Avara, Guru Control Handle, Smart Device) and a digital health platform (XenFi network, XMD cloud, XenME software) that capture real-time procedural data for interventional cardiology, stroke, vascular, and cognitive care, targeting hospitals and medical specialists. All products remain investigational and pre-commercial.

Ownership category

akta.pro rank

Product category

Wireless Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Computer Systems Design Services (541512)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industry

Medical Imaging AI (HDAAAEAH)

Keywords

• Wireless medical devices
• Interventional cardiology
• Clinical data analytics
• Healthcare cloud platform
• Digital health tools

Headquarters

HQ city

Draper

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Wireless Medical Devices: Xenter generates revenue from the sale of wireless smart medical devices including the Avara Smart Device and Guru Control Handle. These devices are workhorse tools used to treat and diagnose structural heart, coronary, stroke, vascular disease, and cognitive disorders.
2. Healthcare Cloud Platform (XMD): Subscription-based access to the XMD global healthcare cloud for AI analytics of Physical Intelligence data, with potential per-transmission or data volume-based pricing.
3. Software Applications (XenME): AI-enabled patient and physician software applications delivered through the XMD cloud, potentially sold as standalone subscriptions or bundled with device purchases.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Xenter develops smart, wireless medical devices—including the Avara Smart Device and Guru Control Handle—that capture "Physical Intelligence," defined as actionable, real-time clinical data from device sensors, imaging, blood tests, and other inputs during procedures. This data is transmitted wirelessly through the XenFi network to Electronic Health Records and the XMD global healthcare cloud, where AI analytics power the XenME patient and provider software applications for clinical decision support. The platform targets interventional treatment and diagnosis of structural heart, coronary, stroke, vascular disease, and cognitive disorders.

Product overview

Xenter is developing a data-driven platform architecture that embeds wireless capabilities into workhorse medical devices. The platform comprises three core components: the XenFi™ wireless network for transmitting Physical Intelligence data, the XMD™ global healthcare cloud for storing and enabling AI analytics, and the XenME™ patient and provider software applications for delivering AI-enabled insights. Supporting these are smart wireless medical devices including Avara Smart Device, Guru Control Handle, and Smart Device that gather Physical Intelligence from the clinical environment. The system targets structural heart, coronary, stroke, vascular disease, and cognitive disorders, and is designed to work with existing EHR systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Avara Smart Device A smart, wireless medical device that gathers Physical Intelligence data from the clinical environment for transmission through the Xenter platform, used to treat and diagnose structural heart, coronary, stroke, vascular disease, and cognitive disorders.
• Guru Control Handle A smart, wireless medical device control handle that gathers Physical Intelligence data from the clinical environment for use in interventional procedures.
• Smart Device A smart, wireless medical device that gathers Physical Intelligence data from the clinical environment for transmission through the Xenter platform.

Quantifiable outcome

• Real-time data capture enables instantaneous clinical decisions during procedures
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators1 record

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Medtronic: Global medtech incumbent with extensive interventional cardiology, structural heart, and cardiac surgery device franchises. Directly comparable to Xenter because Medtronic is the dominant player in the same procedural categories Xenter targets, and its connected device initiatives represent Xenter's most formidable competitive benchmark.
• Abbott: Diversified medtech incumbent with leading positions in interventional cardiology, structural heart, and neuromodulation. Comparable as both a potential competitor and acquirer of Xenter's wireless interventional platform given Abbott's history of integrating connected cardiac care assets.
• Boston Scientific: Major interventional cardiology, peripheral vascular, and neuromodulation device manufacturer. Directly comparable to Xenter across Xenter's structural heart, coronary, and vascular target indications.
• Stryker: Diversified medtech incumbent with a significant neurovascular and stroke intervention business. Comparable as a competitor in Xenter's stroke and vascular target indications and a potential strategic acquirer given its track record of integrating connected interventional platforms.

Direct peers

• Edwards Lifesciences: Specialist in structural heart disease devices, particularly transcatheter heart valves. Closely comparable to Xenter because structural heart is one of Xenter's primary target indications and Edwards represents the gold-standard incumbent Xenter's interventional workflow aims to augment.
• Penumbra: Developer of thrombectomy and stroke intervention devices. Comparable to Xenter because stroke intervention is one of Xenter's named target indications, and Penumbra represents a focused device peer in the same procedural category.
• iRhythm Technologies: Connected cardiac monitoring company combining wearable biosensors with cloud-based AI analytics for arrhythmia detection. Comparable as a peer that pairs wireless medical hardware with a healthcare data cloud and AI software—a closely analogous business model to Xenter's Physical Intelligence stack.

Emerging players

• Imperative Care: Emerging stroke intervention company developing next-generation thrombectomy technologies with integrated data and connectivity features. Comparable as an emerging medtech peer targeting the same stroke intervention workflows Xenter addresses, with a similar emphasis on improving procedural data capture.
• Viz.ai: AI-powered clinical workflow platform for stroke and other time-sensitive conditions. Comparable to Xenter because both companies apply AI to interventional neurology workflows, and Viz.ai represents the data-and-AI layer that Xenter's XMD cloud is positioned to complement or compete with.
• AliveCor: Connected cardiac monitoring company pairing mobile/wireless hardware with AI-driven ECG analytics. Comparable as an emerging medtech peer that pioneered the wireless-device-plus-AI-cloud business model Xenter is extending into the interventional setting.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xenter